2-piperidone has been researched along with Nausea in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Flaherty, KT; Henary, HA; Johnson, DB; Lewis, KD; Long, GV; Moschos, SJ; Puzanov, I; Sandhu, S; Sullivan, RJ; Upreti, VV; Wong, H | 1 |
1 trial(s) available for 2-piperidone and Nausea
Article | Year |
---|---|
Targeting wild-type TP53 using AMG 232 in combination with MAPK inhibition in Metastatic Melanoma; a phase 1 study.
Topics: Acetates; Antineoplastic Combined Chemotherapy Protocols; Humans; Melanoma; Nausea; Piperidones; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidinones; Tumor Suppressor Protein p53 | 2022 |